Commentary: Targeted Renal Therapy: A Potential Weapon in the Battle Against CIN

Abstract

Get full access to this article

View all access options for this article.

References

Nash

Hafeez

Hou

Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930–936.

Walsh

Tang

Gaunt

. Contrast-induced nephropathy. J Endovasc Ther. 2007;14:92–100.

Rudnick

Davidson

Laskey

. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the visipaque angiography/intervention with laboratory outcomes in renal insufficiency (VALOR) trial. Am Heart J. 2008;156:776–782.

Kuhn

Chen

Sahani

. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or iso-osmolar contrast agent exposure. AJR Am J Roentgenol. 2008;191:151–157.

Brar

Shen

Jorgensen

. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA. 2008;300:1038–1046.

Navaneethan

Singh

Appasamy

. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis. 2008[Epub ahead of print].

Weisz

Filby

Cohen

. Safety and performance of targeted renal therapy: the Be-RITe! Registry. J Endovasc Ther. 2009;16:1–12.

Fishbane

Durham

Marzo

. N-acetylcysteine in the prevention of contrast-induced nephropathy. J Am Soc Nephrol. 2004;15:251–260.

Stone

McCullough

Tumlin

. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003;290:2284–2291.

10.

Mehran

Aymong

Nikolsky

. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention; development and initial validation. J Am Coll Cardiol. 2004;44:1391–1399.

11.

McCulloch

Stacul

Davidson

. Overview. Am J Cardiol. 2006;98(Suppl 1):2–4.